Jushi finalizes $91.2 million deal to buy Massachusetts marijuana company

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

Marijuana multistate operator Jushi Holdings revised downward the upfront payment for a deal to enter the Massachusetts market through the acquisition of vertically integrated Nature’s Remedy.

The upfront payment was originally announced as $100 million, but it came in at $91.2 million when the deal closed.

Under terms of the agreement to acquire Nature’s Remedy, Jushi’s payment is made up of:

  • $40 million in cash.
  • $34.7 million in stock.
  • A $11.5 million unsecured three-year note.
  • A $5 million unsecured five-year note.

According to a news release, Jushi paid an additional $2.9 million in cash to acquire excess inventory worth $17.5 million, though the goods are valued at $22.5 million at current wholesale prices.

Jushi also said it expects to issue up to 4.3 million fewer company shares.

Nature’s Remedy operates two retail stores in Massachusetts – in Millbury and Tyngsborough – as well as a 50,000-square-foot cultivation and production facility in Lakeville.

The facility has about 22,000 square feet of indoor flower canopy and extraction and manufacturing space.

“With its strong, defensible retail position and a scalable cultivation footprint, Nature’s Remedy offers significant opportunities for us to expand and grow our presence in this rapidly maturing adult-use market,” Jim Cacioppo, Jushi’s CEO, chair and founder, said in the release.

The 2021 MJBizFactbook projects that recreational marijuana sales in Massachusetts will reach $1.1 billion-$1.4 billion this year, compared with an estimated $625 million-$775 million in 2020.